In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...
3d
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...
Imagine you have just been diagnosed with mild cognitive decline due to Alzheimer’s disease. Your doctor might suggest taking ...
Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.
A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...
A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of research from the University of Gothenburg, which also ...
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback